Is parathyroid hormone (1-84) a safe and effective treatment for postmenopausal osteoporosis?

Affiliations

Comment

Benjamin Z Leder. Nat Clin Pract Endocrinol Metab. 2007 Nov.

. 2007 Nov;3(11):746-7.

doi: 10.1038/ncpendmet0626. Epub 2007 Sep 4.

¹ Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA. bzleder@partners.org

No abstract available

Comment on

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group. Greenspan SL, et al. Ann Intern Med. 2007 Mar 6;146(5):326-39. doi: 10.7326/0003-4819-146-5-200703060-00005. Ann Intern Med. 2007. PMID: 17339618 Clinical Trial.